0001209191-23-038885.txt : 20230621 0001209191-23-038885.hdr.sgml : 20230621 20230621181706 ACCESSION NUMBER: 0001209191-23-038885 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230619 FILED AS OF DATE: 20230621 DATE AS OF CHANGE: 20230621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harris Erik CENTRAL INDEX KEY: 0001780113 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36276 FILM NUMBER: 231031079 MAIL ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc. CENTRAL INDEX KEY: 0001515673 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272546083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-483-8800 MAIL ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-19 0 0001515673 Ultragenyx Pharmaceutical Inc. RARE 0001780113 Harris Erik 60 LEVERONI COURT NOVATO CA 94949 0 1 0 0 EVP & Chief Commercial Officer 0 Common Stock 2023-06-19 4 S 0 305 48.20 D 57281 D Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs"). Includes 242 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2023. Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. /s/ Karah Parschauer, attorney-in-fact 2023-06-21